Alexion Pharmaceuticals, Inc.

This study tested whether an experimental drug called bertilimumab could help control the symptoms of moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. It involved 32 adults and compared the drug's effects against a placebo over 56 days. The trial was t…

This study tested an investigational drug, ALXN2050, in adults with two serious kidney diseases: lupus nephritis and IgA nephropathy. The goal was to see if adding ALXN2050 to standard care could better reduce protein in the urine and protect long-term kidney function. The trial …

This study tested whether the drug ravulizumab could help control kidney damage in adults with lupus nephritis or IgA nephropathy. About 123 participants were randomly assigned to receive either the drug or a placebo infusion to see if it safely reduced protein in their urine, a …

This study tested whether a drug called danicopan could slow the progression of geographic atrophy, a form of age-related macular degeneration that destroys central vision. About 365 participants with the condition took either the drug at different doses or a placebo for up to tw…